Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues?  Seth Joshua Rotz, MD, Thomas D. Ryan,

Published byMihály Lakatos Modified over 5 years ago

Similar presentations

Presentation on theme: "Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues?  Seth Joshua Rotz, MD, Thomas D. Ryan,"— Presentation transcript:

1 Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues?  Seth Joshua Rotz, MD, Thomas D. Ryan, MD, PhD, Adam Lane, PhD, Javier El-Bietar, MD, Sonata Jodele, MD, Anna Maria Holdcroft, MS, Kelly E. Lake, BS, Alyss Anderson, BS, Stella M. Davies, MBBS, PhD, Christopher E. Dandoy, MD, MSc  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S258-S259 (March 2016) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure 1 Percent Positive cTn-l (>0.03 ng/mL)
Biology of Blood and Marrow Transplantation  , S258-S259DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Figure 2 cTn-l in New LV Systolic Dysfunction (by Subject)
Biology of Blood and Marrow Transplantation  , S258-S259DOI: ( /j.bbmt ) Copyright © Terms and Conditions

Download ppt "Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues?  Seth Joshua Rotz, MD, Thomas D. Ryan,"

Similar presentations

Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft.

Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft.
Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review 

Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review 
Topical Ruxolitinib Protects LGR5+ Stem Cells in the Hair Follicle and Ameliorates Skin Graft-Versus-Host Disease  Shuichiro Takahashi, MD, Daigo Hashimoto,

Topical Ruxolitinib Protects LGR5+ Stem Cells in the Hair Follicle and Ameliorates Skin Graft-Versus-Host Disease  Shuichiro Takahashi, MD, Daigo Hashimoto,
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T-Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%  Pooja.

Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T-Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%  Pooja.
How to Treat MDS without Stem Cell Transplantation

How to Treat MDS without Stem Cell Transplantation
Kristen M. Coleman, RN, BSN, Stella M

Kristen M. Coleman, RN, BSN, Stella M
Biology of Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation
Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation  Javier.

Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation  Javier.
Outcomes of Diffuse Large B-Cell Lymphoma (DLBCL) Patients Progressing after Autologous Hematopoietic Stem Cell Transplant  Maria Gil-Cupello, BA, Gunjan.

Outcomes of Diffuse Large B-Cell Lymphoma (DLBCL) Patients Progressing after Autologous Hematopoietic Stem Cell Transplant  Maria Gil-Cupello, BA, Gunjan.
T-Cell Acute Lymphoblastic Lymphoma (T-LBL) and Stem Cell Transplantation (SCT): A Comparison of Outcomes with T-Cell Acute Lymphoblastic Leukemia (T-ALL) 

T-Cell Acute Lymphoblastic Lymphoma (T-LBL) and Stem Cell Transplantation (SCT): A Comparison of Outcomes with T-Cell Acute Lymphoblastic Leukemia (T-ALL) 
Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral.

Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral.
A Response Adapted Approach to Induction Treatment in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation  Gunjan L. Shah,

A Response Adapted Approach to Induction Treatment in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation  Gunjan L. Shah,
Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,

Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,
Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E

Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E
Vitamin A Deficiency Is Associated with Increased Risk of Acute Graft Versus Host Disease in Children  Dana T. Lounder, MD, Sonata Jodele, MD, Pooja Khandelwal,

Vitamin A Deficiency Is Associated with Increased Risk of Acute Graft Versus Host Disease in Children  Dana T. Lounder, MD, Sonata Jodele, MD, Pooja Khandelwal,
Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,
Systematic Anti-Mold Prophylaxis Results in Very Low Incidence of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation 

Systematic Anti-Mold Prophylaxis Results in Very Low Incidence of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation 
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA) 

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA) 
Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,

Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,
CD34-Selected, T Cell Depleted Haploidentical Donor Peripheral Blood Stem Cell (PBSC) Transplantation in Children with Malignant (MD) and Non-Malignant.

CD34-Selected, T Cell Depleted Haploidentical Donor Peripheral Blood Stem Cell (PBSC) Transplantation in Children with Malignant (MD) and Non-Malignant.

Similar presentations

Ads by Google